Kongenitaler Hyperinsulinismus (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kongenitaler Hyperinsulinismus" in German language version.

refsWebsite
Global rank German rank
4th place
7th place
5,673rd place
995th place
2nd place
3rd place

doi.org

  • H. Demirbilek, K. Hussain: Congenital Hyperinsulinism: Diagnosis and Treatment Update. In: Journal of clinical research in pediatric endocrinology. Band 9, Suppl 2Dezember 2017, S. 69–87, doi:10.4274/jcrpe.2017.S007, PMID 29280746, PMC 5790328 (freier Volltext) (Review).
  • J. B. Arnoux, V. Verkarre, C. Saint-Martin, F. Montravers, A. Brassier, V. Valayannopoulos, F. Brunelle, J. C. Fournet, J. J. Robert, Y. Aigrain, C. Bellanné-Chantelot, P. de Lonlay: Congenital hyperinsulinism: current trends in diagnosis and therapy. In: Orphanet Journal of Rare Diseases. Band 6, Oktober 2011, S. 63, doi:10.1186/1750-1172-6-63, PMID 21967988, PMC 3199232 (freier Volltext) (Review).
  • C. James, R. R. Kapoor, D. Ismail, K. Hussain: The genetic basis of congenital hyperinsulinism. In: Journal of medical genetics. Band 46, Nummer 5, Mai 2009, S. 289–299, doi:10.1136/jmg.2008.064337, PMID 19254908 (Review).
  • C. A. Stanley, Y. K. Lieu, B. Y. Hsu, A. B. Burlina, C. R. Greenberg, N. J. Hopwood, K. Perlman, B. H. Rich, E. Zammarchi, M. Poncz: Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. In: The New England Journal of Medicine. Band 338, Nummer 19, Mai 1998, S. 1352–1357, doi:10.1056/NEJM199805073381904, PMID 9571255.
  • C. A. Stanley: Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders. In: The Journal of Clinical Endocrinology and Metabolism. Band 101, Nummer 3, März 2016, S. 815–826, doi:10.1210/jc.2015-3651, PMID 26908106, PMC 4803157 (freier Volltext) (Review).
  • C. A. Stanley: Hyperinsulinism/hyperammonemia syndrome: insights into the regulatory role of glutamate dehydrogenase in ammonia metabolism. In: Molecular Genetics and Metabolism. Band 81 Suppl 1, April 2004, S. S45–S51, doi:10.1016/j.ymgme.2003.10.013, PMID 15050973 (Review).
  • P. T. Clayton, S. Eaton, A. Aynsley-Green, M. Edginton, K. Hussain, S. Krywawych, V. Datta, H. E. Malingre, R. Berger, I. E. van den Berg: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. In: The Journal of clinical investigation. Band 108, Nummer 3, August 2001, S. 457–465, doi:10.1172/JCI11294, PMID 11489939, PMC 209352 (freier Volltext).
  • C. Li, P. Chen, A. Palladino, S. Narayan, L. K. Russell, S. Sayed, G. Xiong, J. Chen, D. Stokes, Y. M. Butt, P. M. Jones, H. W. Collins, N. A. Cohen, A. S. Cohen, I. Nissim, T. J. Smith, A. W. Strauss, F. M. Matschinsky, M. J. Bennett, C. A. Stanley: Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase. In: Journal of Biological Chemistry. Band 285, Nummer 41, Oktober 2010, S. 31806–31818, doi:10.1074/jbc.M110.123638, PMID 20670938, PMC 2951252 (freier Volltext).
  • A. J. Heslegrave, K. Hussain: Novel insights into fatty acid oxidation, amino acid metabolism, and insulin secretion from studying patients with loss of function mutations in 3-hydroxyacyl-CoA dehydrogenase. In: The Journal of Clinical Endocrinology and Metabolism. Band 98, Nummer 2, Februar 2013, S. 496–501, doi:10.1210/jc.2012-3134, PMID 23253615 (Review).

nih.gov

ncbi.nlm.nih.gov

  • H. Demirbilek, K. Hussain: Congenital Hyperinsulinism: Diagnosis and Treatment Update. In: Journal of clinical research in pediatric endocrinology. Band 9, Suppl 2Dezember 2017, S. 69–87, doi:10.4274/jcrpe.2017.S007, PMID 29280746, PMC 5790328 (freier Volltext) (Review).
  • J. B. Arnoux, V. Verkarre, C. Saint-Martin, F. Montravers, A. Brassier, V. Valayannopoulos, F. Brunelle, J. C. Fournet, J. J. Robert, Y. Aigrain, C. Bellanné-Chantelot, P. de Lonlay: Congenital hyperinsulinism: current trends in diagnosis and therapy. In: Orphanet Journal of Rare Diseases. Band 6, Oktober 2011, S. 63, doi:10.1186/1750-1172-6-63, PMID 21967988, PMC 3199232 (freier Volltext) (Review).
  • C. James, R. R. Kapoor, D. Ismail, K. Hussain: The genetic basis of congenital hyperinsulinism. In: Journal of medical genetics. Band 46, Nummer 5, Mai 2009, S. 289–299, doi:10.1136/jmg.2008.064337, PMID 19254908 (Review).
  • C. A. Stanley, Y. K. Lieu, B. Y. Hsu, A. B. Burlina, C. R. Greenberg, N. J. Hopwood, K. Perlman, B. H. Rich, E. Zammarchi, M. Poncz: Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. In: The New England Journal of Medicine. Band 338, Nummer 19, Mai 1998, S. 1352–1357, doi:10.1056/NEJM199805073381904, PMID 9571255.
  • C. A. Stanley: Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders. In: The Journal of Clinical Endocrinology and Metabolism. Band 101, Nummer 3, März 2016, S. 815–826, doi:10.1210/jc.2015-3651, PMID 26908106, PMC 4803157 (freier Volltext) (Review).
  • C. A. Stanley: Hyperinsulinism/hyperammonemia syndrome: insights into the regulatory role of glutamate dehydrogenase in ammonia metabolism. In: Molecular Genetics and Metabolism. Band 81 Suppl 1, April 2004, S. S45–S51, doi:10.1016/j.ymgme.2003.10.013, PMID 15050973 (Review).
  • S. Chandran, F. Yap, K. Hussain: Molecular mechanisms of protein induced hyperinsulinaemic hypoglycaemia. In: World J Diabetes. 5, 2014, S. 666–677, PMID 25317244 PMC 4138590 (freier Volltext).
  • P. T. Clayton, S. Eaton, A. Aynsley-Green, M. Edginton, K. Hussain, S. Krywawych, V. Datta, H. E. Malingre, R. Berger, I. E. van den Berg: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. In: The Journal of clinical investigation. Band 108, Nummer 3, August 2001, S. 457–465, doi:10.1172/JCI11294, PMID 11489939, PMC 209352 (freier Volltext).
  • A. Molven, G. E. Matre, M. Duran, R. J. Wanders, U. Rishaug, P. R. Njølstad, E. Jellum, O. Søvik: Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. In: Diabetes. Band 53, Nummer 1, Januar 2004, S. 221–227, PMID 14693719.
  • C. Li, P. Chen, A. Palladino, S. Narayan, L. K. Russell, S. Sayed, G. Xiong, J. Chen, D. Stokes, Y. M. Butt, P. M. Jones, H. W. Collins, N. A. Cohen, A. S. Cohen, I. Nissim, T. J. Smith, A. W. Strauss, F. M. Matschinsky, M. J. Bennett, C. A. Stanley: Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase. In: Journal of Biological Chemistry. Band 285, Nummer 41, Oktober 2010, S. 31806–31818, doi:10.1074/jbc.M110.123638, PMID 20670938, PMC 2951252 (freier Volltext).
  • A. J. Heslegrave, K. Hussain: Novel insights into fatty acid oxidation, amino acid metabolism, and insulin secretion from studying patients with loss of function mutations in 3-hydroxyacyl-CoA dehydrogenase. In: The Journal of Clinical Endocrinology and Metabolism. Band 98, Nummer 2, Februar 2013, S. 496–501, doi:10.1210/jc.2012-3134, PMID 23253615 (Review).

uniprot.org